Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Dana Brata Luhur Tbk. (TEBE) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Dana Brata Luhur Tbk.Trade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Dana Brata Luhur Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Dana Brata Luhur Tbk. trades at Rp1,010 (market cap 1.3T, 222.6K 24h volume). The key difference: Dana Brata Luhur Tbk. is far larger — about 4.2× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 222.6K). Which is the better fit depends on your goals.

DGNSTEBE
Market Cap
310.75B1.3T
Volume
963.6K222.6K
Lot
9.64K2.23K
Turnover
217.67M224.14M
Average Price
225.891,006.9
Value
217.67M224.14M
Indicative Equilibrium Price
2261,010
Indicative Equilibrium Volume
1K1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
TEBE
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Dana Brata Luhur Tbk.

PT Dana Brata Luhur Tbk (the Company) was established based on Notarial Deed No. 52 dated June 26, 2008 of Bonar Sihombing, S.H., a public notary in Jakarta and the Deed of Amendment on the Articles of Association No. 2 dated December 18, 2008.

Read more on TEBE